1. Characterization of immortalized ovarian epithelial cells with BRCA1/2 mutation
   Hiroaki Komatsu et al, 2024, Human Cell CrossRef
2. Detection of dual-methylated BRCA1/BRCA2 cell-free DNA for ovarian cancer on an aptamer-based integrated microfluidic system
   Chih-Hung Wang et al, 2024, Chemical Engineering Journal CrossRef
3. Limitations of homologous recombination status testing and poly (ADP-ribose) polymerase inhibitor treatment in the current management of ovarian cancer
   Qianying Zhao et al, 2024, Frontiers in Oncology CrossRef
4. PARP inhibitors in ovarian cancer: Mechanisms, resistance, and the promise of combination therapy
   Tejas Bhatia et al, 2024, Pathology - Research and Practice CrossRef
5. Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer
   Yu Huang et al, 2023, International Journal of Molecular Sciences CrossRef